ATER has traded down to a support level and 0.62 Fib retracement. ATER has an upcoming pharmaceutical approval from the FDA for one of their drugs which remains in stage 2 trials.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
